BioPharma & Life Sciences Connected Live (BLSC2026)

Event date: January 28th, 2026
Venue: Radisson Blu Hotel & Spa
City/Country: Cork, Ireland
Format: Conference and Exhibition (full-day schedule with keynote talks, panels, Q&A, and networking)

What the event is about

BioPharma & Life Sciences Connected Live is positioned as a focused industry forum for biopharmaceutical and life sciences manufacturing. The event centers on hearing directly from leading national and international experts and stakeholders who share real-world challenges and solutions from pharmaceutical manufacturing contexts. The biopharma sector in Ireland is highlighted as currently facing pressures and transformation needs across areas such as supply chain, digital transformation, automation, carbon reduction, and regulatory changes.

The event states that over 75 leading speakers will participate, delivering keynote talks and panel debates across topics shaping the sector, and over 70 exhibitors will be on-site showcasing new and innovative products. It also emphasizes networking across the day, as well as association engagement (industry bodies and government agencies).

Who attends (BUYERS / ATTENDEES)

This event is not a general consumer or broad tech conference; it is a biopharma/life sciences manufacturing event. As a result, the most valuable “buyer” attendees typically come from organizations that either operate manufacturing facilities, own transformation programs, or sell/enable manufacturing technologies, engineering, compliance, and process systems.

Primary attendee groups (how we would segment buyers/decision-makers)

• Biopharma & biotech manufacturing leaders: people responsible for bringing products to market, improving yield, reducing batch failures, and ensuring reliable operations under changing regulatory requirements.
• Process and engineering roles: stakeholders focused on process optimization, integration, plant engineering, HVAC & cleanroom engineering, and practical implementation of new production approaches.
• Digital transformation and automation stakeholders: those driving digitalisation, IoT/Industry 4.0 adoption, automation strategies, and modernization of plant data and controls.
• Technology transfer / validation / quality-adjacent stakeholders: people supporting tech transfer readiness, scalable manufacturing execution, and consistent best practices for biosimilars.
• Vendors, OEMs, and technology solution providers (exhibitors): exhibitors showcasing manufacturing technologies across areas like hybrid systems (single-use and/or stainless steel), automation, and engineering solutions supporting clean environments.
• Associations and government agencies: the event explicitly indicates that participants can meet industry associations and government agencies, which often influence standards, workforce and policy direction, and regional industry priorities.

In practical terms, the strongest buyer fit tends to be organizations that: (1) run or modernize biopharmaceutical manufacturing operations, (2) invest in automation, digitalization, and cleanroom/HVAC environments, or (3) supply core enabling technologies (process, integration, and manufacturing systems) to those operators.

Where the show is happening + attendee geographic origin

Location: Radisson Blu Hotel & Spa, Cork, Ireland.
The event explicitly connects its focus to challenges in the biopharma sector in Ireland, so we would expect substantial attendance from Irish industry stakeholders.

Attendee geographic origin (reliably inferred from the event positioning)

• Primary: Ireland-based biopharma operators, engineering organizations, and life sciences manufacturing stakeholders.
• Secondary: UK and broader European participation is plausible given the “national and international experts” framing, and the EMEA references in named speakers.
• Global reach (limited but present): the event references national and international experts; however, the strongest “core” is Ireland/EMEA rather than a truly global, multi-continent audience.

Because the official text provided does not include a stated breakdown of attendee origin by country, we treat geographic reach as Ireland-first with meaningful EMEA participation, without claiming precise percentages.

Audience reach (Local / National / Global)

The event is best classified as a regional-to-national industry conference with international expert participation. It is locally anchored in Ireland (explicitly emphasized in the event description) but draws “leading national and international experts” and includes speaker and stakeholder participation across the biopharma manufacturing ecosystem.

• Local: Strong concentration likely from Cork and other Irish biopharma manufacturing clusters.
• National: Stronger-than-local relevance for Ireland-based companies and institutions.
• Global: Limited compared to worldwide mega-events, but the content and expert mix suggest international relevance.

Sample buyer company names (BUYERS ONLY) + websites

Below are representative buyer-style organizations that commonly align with the event theme (biopharmaceutical manufacturing, process optimization, automation/digitalisation, cleanroom/HVAC, integration, and life sciences engineering). Where possible, the samples also align with the types of speakers/exhibitor categories referenced in the official event content.

Note: This table is intended for buyer targeting and outreach research. Exact exhibitor/buyer presence for every company should be confirmed via the official exhibitor/sponsor lists for the event cycle.

Top buyer samples to send first (for a faster first pass)

• Multivac — Head of Biopharma/Life Sciences Business Development
• Control Station Ltd — Integration Director (EMEA)/Automation Integration Lead
• SIA Partners — Life Sciences Transformation Manager
• Exyte — Lead Process Engineer / SME
• Thermo Fisher Scientific — Biopharma Engineering Program Manager / Automation & Digital Lead

Job profiles, industries & event type

Best job profiles to target (based on the event’s key topics)

• Director of Biopharma / Life Sciences Business Development
• Head of Bioprocess Engineering / Lead Process Engineer
• Integration Director (EMEA) / Automation Integration Lead
• Director, Digitalisation & Connected Manufacturing
• IoT & Industry 4.0 Program Manager
• Process Optimization Manager / Manufacturing Excellence Leader
• Technology Transfer Lead / Tech Transfer Program Manager
• Facilities Director / GMP Facilities Manager
• HVAC & Cleanroom Engineering Manager
• Automation & Controls Manager
• Biosimilars Manufacturing Lead / Best-Practice Implementation Manager
• Hybrid Systems (Single-use & Stainless) Strategy Lead
• Cell & Gene Therapy Manufacturing Operations Lead
• Carbon Reduction / Energy Optimization Program Lead (where applicable)
• Project/Program Director for ultrafast execution or turnkey programs

Event type

• Conference and Exhibition
• Keynote talks, panels, and Q&A
• Technology showcasing by exhibitors (over 70 exhibitors referenced)
• Networking throughout the day

Estimated attendance (expected total footfall)

The official event text provided does not include a stated numeric attendance figure (e.g., “expected total attendees”). We would therefore treat attendance as not specified in the provided primary text, and recommend confirming expected attendee count via the event’s “FAQ” or “Networking Guide” sections if available.

Key focus areas & buyer engagement

Key topics included (directly from the official event text)

• Research & Innovation
• Automation
• Vaccine Manufacturing
• Process Optimisation
• Tech Transfer
• Digitalisation
• IoT & Industry 4.0
• Covid-19 impact to the market
• Hybrid Systems – Single Use and/or Stainless Steel
• Biosimilars – Best-Practice
• Ultrafast Project Execution
• Turnkey
• HVAC & Cleanroom Engineering
• Cell & Gene Therapy

How buyers are likely to engage

• By solution fit to transformation needs: attendees commonly engage around practical “how to implement” case-study learning, because the event states that spotlight presentations will be on case studies from pharmaceutical companies.
• Through Q&A and panels: the agenda supports targeted questions on execution constraints, regulatory impacts, and integration pathways for automation/digitalisation in real manufacturing settings.
• At the exhibition: exhibitors can position products around automation, hybrid systems, facility engineering, and enabling tech transfer workflows.
• Through association and government touchpoints: this matters for companies navigating standards, compliance direction, and regional sector initiatives tied to Ireland’s biopharma transformation context.

Client-product fit note (buyers who are likely to buy, and next step for exact recommendations)

We can refine the “best buyers” list to match your client requirements, but we need your client product fit details exactly as described on your client’s website. Please share the client website URL. Once we review it, we will return: (1) the best buyer segments from this event context, (2) recommended job titles to target, (3) a prioritized buyer list aligned to the client’s use-cases (e.g., automation/digitalisation vs. cleanroom engineering vs. tech transfer).

What we will do after you share the website

• Map your client’s product to the event’s key topics (automation, IoT/Industry 4.0, hybrid systems, HVAC & cleanroom, tech transfer, cell & gene therapy, turnkey delivery).
• Select only buyer profiles that are decision-makers or influencers for that product category.
• Prioritize buyers in the biopharma manufacturing ecosystem most likely to have immediate transformation budgets and active project pipelines.
• Provide an action-ready shortlist (highest-fit companies first).

Suggested industries (based on an Apollo-style industry list)

Since this event is focused on biopharmaceutical manufacturing and life sciences operations, we recommend prioritizing these industries from your available taxonomy:

• Pharmaceuticals
• Hospital & Health Care
• Medical Devices
• Biotechnology
• Renewables & Environment (when targeting carbon reduction / energy programs)
• Industrial Automation (for automation and controls-led solutions)
• Mechanical or Industrial Engineering (for process engineering and plant engineering)
• Computer Software / Computer & Network Security (only if your client solution is software/connected manufacturing or cybersecurity adjacent)
• Research (if client offers research-to-manufacturing enablement or lab-to-process scaling tools)
• Events Services (only for event-related service providers; generally lower priority for biopharma buyers)
• Logistics & Supply Chain (when targeting supply-chain resilience topics mentioned in the event context)

Final buyer targeting summary (how we would position We’s research)

• Best buyer fit: biopharma and life sciences manufacturing operators and transformation leaders, plus exhibitors delivering enabling technologies around automation, digitalisation, integration, tech transfer, hybrid systems, and cleanroom/HVAC facility engineering.
• Best engagement angles: transformation execution case studies, practical implementation pathways, and topic-specific solution mapping (automation, IoT/Industry 4.0, ultrafast/turnkey delivery, and cell & gene therapy readiness).
• Best geography focus: Cork and Ireland-first, then broader EMEA (since the official materials position includes national and international experts).
• Next step for exact “best buyers”: share your client website URL so we can refine the buyer shortlist based on your client’s actual product category and intended outcomes.